# The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

> **NCT06287320** · — · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 200 (estimated)

## Conditions studied

- Locally Advanced Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** concurrent or sequential chemoradiotherapy
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT06287320
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06287320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06287320, "The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06287320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*